| Biovail Americas Corporation and subsidiaries | New Jersey | state | 2013 | $39,502,500 | | tax credit/rebate |
| Bausch & Lomb Incorporated | New York | state | 2015 | $9,000,000 | | tax credit/rebate |
| Valeant Pharmaceuticals North America LLC and | New Jersey | state | 2003 | $4,325,100 | | grant |
| Bausch & Lomb Incorporated | New Jersey | state | 2008 | $3,500,000 | | grant |
| Bausch & Lomb Incorporated(2) | New York | state | 2019 | $3,000,000 | | tax credit/rebate |
| Bausch & Lomb Incorporated | New York | state | 2006 | $1,599,567 | | enterprise zone |
| Bausch & Lomb Incorporated | New York | state | 2010 | $1,517,457 | | enterprise zone |
| Bausch & Lomb Incorporated | New York | state | 2011 | $1,490,125 | | enterprise zone |
| Bausch & Lomb Incorporated | New York | state | 2012 | $1,416,700 | | enterprise zone |
| Bausch & Lomb Incorporated | New York | state | 2008 | $1,187,088 | | enterprise zone |
| Bausch & Lomb Incorporated | New York | state | 2009 | $1,169,891 | | enterprise zone |
| Bausch & Lomb Incorporated | New York | state | 2007 | $1,123,304 | | enterprise zone |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2013 | $1,077,666 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2013 | $1,077,666 | | tax credit/rebate |
| Bausch & Lomb Incorporated | New York | local | 2015 | $709,291 | | tax credit/rebate |
| Bausch & Lomb Incorporated | New York | state | 2005 | $680,000 | | enterprise zone |
| BAUSH & LOMB | South Carolina | state | 2010 | $615,965 | | training reimbursement |
| Bausch & Lomb R&D | New York | local | 2006 | $605,264 | | tax credit/rebate; property tax abatement |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2006 | $489,383 | | federal grant |
| Bausch & Lomb Incorporated | New York | local | 2016 | $446,809 | | tax credit/rebate |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2005 | $421,273 | | federal grant |
| Bausch & Lomb Incorporated | New York | state | 2013 | $375,037 | | enterprise zone |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2015 | $271,549 | | tax credit/rebate |
| Bausch & Lomb | New York | local | 2003 | $266,156 | | tax credit/rebate; property tax abatement |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2014 | $253,035 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2014 | $253,035 | | tax credit/rebate |
| Bausch & Lomb | New York | local | 2004 | $214,683 | | tax credit/rebate; property tax abatement |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2015 | $203,458 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2014 | $185,492 | | tax credit/rebate |
| Bausch & Lomb Incorporated | New York | local | 2017 | $150,152 | | tax credit/rebate |
| Bausch & Lomb | New York | local | 2005 | $145,551 | | tax credit/rebate; property tax abatement |
| Bausch & Lomb Incorporated - Clearwater Facility | Florida | state | 2005 | $135,000 | | tax credit/rebate |
| Bausch & Lomb Incorporated | New York | Local | 2018 | $119,960 | | tax credit/rebate |
| Bausch & Lomb Incorporated | New York | local | 2019 | $119,959 | | tax credit/rebate |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2004 | $100,000 | | federal grant |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2011 | $96,902 | | tax credit/rebate |
| DOW PHARMACEUTICAL SCIENCES | United States | federal | 2005 | $86,650 | | federal grant |
| Valeant Pharmaceuticals International | North Carolina | state | 2016 | $82,963 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2010 | $68,808 | | tax credit/rebate |
| Bausch & Lomb | Florida | state | 2010 | $50,000 | | training reimbursement |
| Bausch & Lomb | Florida | state | 2012 | $47,493 | | training reimbursement |
| Valeant Pharmaceuticals International | North Carolina | state | 2013 | $47,287 | | tax credit/rebate |
| Valeant Pharmaceuticals International | North Carolina | state | 2013 | $47,287 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2016 | $39,370 | | tax credit/rebate |
| Valeant Pharmaceuticals International | North Carolina | state | 2015 | $27,309 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2011 | $21,024 | | tax credit/rebate |
| Bausch & Lomb Inc. | New York | local | 2019 | $20,253 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2011 | $15,000 | | tax credit/rebate |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2008 | $10,777 | | tax credit/rebate |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2009 | $10,777 | | tax credit/rebate |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2010 | $10,777 | | tax credit/rebate |
| Salix Pharmaceuticals, Inc. | North Carolina | state | 2013 | $8,650 | | tax credit/rebate |
| Bausch & Lomb Incorporated | Massachusetts | state | 2011 | $7,623 | | tax credit/rebate |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2013 | $5,646 | | tax credit/rebate |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2013 | $5,646 | | tax credit/rebate |
| Buasch & Lomb | Florida | local | 2005 | $4,795 | | grant |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2015 | $3,313 | | tax credit/rebate |
| Sprout Pharmaceuticals, Inc. | North Carolina | state | 2016 | $2,940 | | tax credit/rebate |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2004 | undisclosed | | tax credit/rebate |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2005 | undisclosed | | tax credit/rebate |
| MEDICIS TECHNOLOGIES CORPORATION | Washington | state | 2008 | undisclosed | | tax credit/rebate |
| MEDICIS THE DERMATOLOGY CO | California | local | 2012 | undisclosed | | tax credit/rebate |
. 